Cargando…

CA724 Predicts Tumor Regression Grade in Locally Advanced Gastric Cancer Patients with Neoadjuvant Chemotherapy

Purpose: Tumor regression grade (TRG) is widely used to evaluate the efficacy of neoadjuvant chemotherapy (NCT) and it is related to many clinicopathological factors. However, whether TRG can be predicted by clinical characteristics is unknown. Methods: 141 locally advanced gastric cancer (GC) patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Yilin, Zhu, Yanmei, Zhao, Yan, Jiang, Chengyao, Wang, Wentao, Shan, Zexing, Sun, Fan, Liu, Dong, Zhang, Jianjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489128/ https://www.ncbi.nlm.nih.gov/pubmed/34659537 http://dx.doi.org/10.7150/jca.60694

Ejemplares similares

CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy
por: Tong, Yilin, et al.
Publicado: (2021)

Tumor Regression Grade Predicts Survival in Locally Advanced Gastric Adenocarcinoma Patients with Lymph Node Metastasis
por: Tong, Yilin, et al.
Publicado: (2020)

Predictive value of NLR and PLR in response to preoperative chemotherapy and prognosis in locally advanced gastric cancer
por: Wang, Wentao, et al.
Publicado: (2022)

Evaluation and Comparison of Predictive Value of Tumor Regression Grades according to Mandard and Becker in Locally Advanced Gastric Adenocarcinoma
por: Tong, Yilin, et al.
Publicado: (2021)

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021)

Extracellular vesicles in gastric cancer: role of exosomal lncRNA and microRNA as diagnostic and therapeutic targets
por: Jiang, Chengyao, et al.
Publicado: (2023)

Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer
por: Shan, Zexing, et al.
Publicado: (2021)

CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant Chemotherapy
por: Chen, Yong, et al.
Publicado: (2022)

Study on the Differential Value of Tumor Marker CA724 on Primary Gastric Cancer
por: Ding, Jieying, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy in Asian Patients With Locally Advanced Gastric Cancer
por: Tong, Xie, et al.
Publicado: (2023)

Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer
por: Martin-Romano, Patricia, et al.
Publicado: (2016)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
por: Xie, Jian-Wei, et al.
Publicado: (2021)

Determination of serum CA724 levels using fluorescence immunochromatography
por: Liu, Chang, et al.
Publicado: (2023)

Serum CA724 has no diagnostic value for gastrointestinal tumors
por: Cao, Huiru, et al.
Publicado: (2023)

Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy
por: Xu, Wei, et al.
Publicado: (2021)

The predictive value of histological tumor regression grading (TRG) for therapeutic evaluation in locally advanced esophageal carcinoma treated with neoadjuvant chemotherapy
por: Guo, Kang, et al.
Publicado: (2012)

Lymph node regression grading of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
por: He, Lei, et al.
Publicado: (2022)

Clinical Value on Combined Detection of Serum CA724, DKK1, and TK1 in Diagnosis of Gastric Cancer
por: Wang, Yu, et al.
Publicado: (2022)

Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Wang, Yinkui, et al.
Publicado: (2020)

Spatial distribution characteristics of tumor marker CA724 reference values in China
por: Jing, Jing, et al.
Publicado: (2019)

High expressions of CD10, FAP and GPR77 in CAFs are associated with chemoresistance and worse prognosis in gastric cancer
por: Tong, Yilin, et al.
Publicado: (2022)

Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei
por: Liang, Lei, et al.
Publicado: (2021)

Neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: our experience in the elderly
por: Bugiantella, W, et al.
Publicado: (2009)

A Retrospective Study of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Wang, Yajing, et al.
Publicado: (2020)

Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Liu, Zining, et al.
Publicado: (2021)

Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients
por: Ding, Yuqin, et al.
Publicado: (2020)

Risk Factors to Predict Ocular Metastasis in Older Adult Patients With Gastric Cancer:LDL, ApoA1, and CA724
por: Shi, Wen-Qing, et al.
Publicado: (2022)

The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients
por: Kuang, Jiaan, et al.
Publicado: (2020)

Diagnostic and prognostic values of anti‐helicobacter pylori antibody combined with serum CA724, CA19‐9, and CEA for young patients with early gastric cancer
por: Gong, Xuyang, et al.
Publicado: (2020)

Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
por: An, Ji Yeong, et al.
Publicado: (2013)

A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay)
por: Liu, Chang, et al.
Publicado: (2022)

Tumor regression grade combined with post‐therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma
por: Yin, Hongyan, et al.
Publicado: (2023)

Associations between serum CA724 and HER2 overexpression among stage II–III resectable gastric cancer patients: an observational study
por: Chen, Xin-Zu, et al.
Publicado: (2016)

Retracted: A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay)
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Identification of the Prognosis-Related lncRNAs and Genes in Gastric Cancer
por: Su, Xiaohui, et al.
Publicado: (2020)

Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer
por: Zhou, Jichun, et al.
Publicado: (2016)

The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Ge, Rui, et al.
Publicado: (2022)

Clinical Value of PLR, MLR, and NWR in Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: He, Baojun, et al.
Publicado: (2022)

Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
por: Li, Song, et al.
Publicado: (2023)

Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy
por: Zhu, Yue-Lu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_51q8h0aip8ngh66og041jo6n91